Dawei Shi
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 25, 2023
Model-based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non-complicated methicillin-resistant staphylococcus aureus infection.Xiao-Shan Zhang, Ye-Li Chen, Yu-Zhen Wang
|Nov 08, 2022
Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.Haixia Shao, Dawei Shi, Ying Dai
|Mar 26, 2021
Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database.Ziye Zhou, Chenxiang Wang, Lili Ying
|Aug 11, 2020
Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System.Ying Dai, Yingying Wang, Yifan Zeng
|Sep 27, 2019
Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin.Xiaofeng Pan, Ziye Zhou, Xiangxiang Jin
|Jun 12, 2019
Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.Dawei Shi, Ziye Zhou, Ying Dai
Pageof 1
